Burcon Nutrascience Corporation BU.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 559.77% | 493.23% | 332.70% | 186.43% | 13.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 559.77% | 493.23% | 332.70% | 186.43% | 13.02% |
| Cost of Revenue | 291.31% | 697.68% | 941.32% | 1,187.41% | 1,251.26% |
| Gross Profit | -237.38% | -789.78% | -1,590.18% | -4,092.55% | -1,224.36% |
| SG&A Expenses | -10.92% | -23.09% | -26.71% | -22.26% | -15.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.75% | 69.92% | 42.32% | 21.48% | 16.50% |
| Operating Income | -44.46% | -48.79% | -29.38% | -15.56% | -16.71% |
| Income Before Tax | -54.69% | -78.36% | -56.86% | -30.17% | -29.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.57% | -73.57% | -56.86% | -30.17% | -29.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.57% | -73.57% | -56.86% | -30.17% | -29.70% |
| EBIT | -44.46% | -48.79% | -29.38% | -15.56% | -16.71% |
| EBITDA | -12.73% | -46.14% | -26.51% | -11.78% | -12.08% |
| EPS Basic | -6.62% | -5.21% | 10.86% | 19.83% | 9.19% |
| Normalized Basic EPS | -11.03% | -8.10% | 10.88% | 19.85% | 9.21% |
| EPS Diluted | -6.81% | -5.18% | 10.66% | 19.65% | 8.99% |
| Normalized Diluted EPS | -11.03% | -8.10% | 10.88% | 19.85% | 9.21% |
| Average Basic Shares Outstanding | 37.71% | 62.28% | 73.57% | 59.51% | 44.09% |
| Average Diluted Shares Outstanding | 37.71% | 62.28% | 73.57% | 59.51% | 44.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |